It is evident that high expression of CD47 promotes tumor invasion and metastasis through Cdc42, and the level of CD47 is associated with tumor stage and lymph node and distant metastasis, especially in NSCLC; therefore, CD47 can be used as a biomarker for the prognosis of NSCLC. The gene discussed is CDC42; the disease is neoplasm.